US 12,454,680 B2
Vero cell line that can be suspension-cultured in serum-free medium, preparation method therefor, and method for preparing viruses for vaccines by using novel cell line
Jun-seok Kwak, Gyeonggi-do (KR); Eun-som Kim, Gyeonggi-do (KR); Hun Kim, Gyeonggi-do (KR); Ki-weon Seo, Gyeonggi-do (KR); Kun Se Lee, Gyeonggi-do (KR); Sujeen Lee, Gyeonggi-do (KR); and Seung-hye Hong, Gyeonggi-do (KR)
Assigned to SK BIOSCIENCE CO., LTD., Gyeonggi-do (KR)
Appl. No. 17/780,093
Filed by SK BIOSCIENCE CO., LTD., Gyeonggi-do (KR)
PCT Filed Nov. 25, 2020, PCT No. PCT/KR2020/016866
§ 371(c)(1), (2) Date May 26, 2022,
PCT Pub. No. WO2021/107612, PCT Pub. Date Jun. 3, 2021.
Claims priority of application No. 10-2019-0154749 (KR), filed on Nov. 27, 2019.
Prior Publication US 2022/0411760 A1, Dec. 29, 2022
Int. Cl. C12N 5/071 (2010.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01)
CPC C12N 5/0686 (2013.01) [A61K 39/12 (2013.01); C12N 7/00 (2013.01); A61K 2039/525 (2013.01); C12N 2500/90 (2013.01); C12N 2770/24134 (2013.01); C12N 2770/24152 (2013.01)] 9 Claims
 
1. A Vero cell line sVERO 7C2 deposited under accession number KCLRF-BP-00470.